Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonazepam plus low-dose morphine for refractory breathlessness
ACTRN12610000589088Phase 3Withdrawn
- Sponsor
- Flinders University
- Start
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of clonazepam and morphine in Chronic breathlessness syndrome, sponsored by Flinders University. Primary endpoint: Average breathlessness in previous 12 hours. Planned start Aug 2010; status: withdrawn.
02
Drugs
clonazepammorphine
03
Conditions
Chronic breathlessness syndrome
Beyond the preview
Go deeper on ACTRN12610000589088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000589088.